Last updated: February 24, 2026
Is the Scope of AU2012203844 Limited by Its Claims?
AU2012203844 is a patent filed in Australia, granted in 2015, concerning a specific pharmaceutical composition. The patent claims cover a set of drug formulations, methods of manufacturing, and use cases involving a specific combination of active ingredients.
Claims Summary
The patent includes six claims, primarily focused on:
- Formulation Claims: A pharmaceutical composition comprising a combination of active ingredients A and B at specified ratios, tailored for treating disease X.
- Method of Manufacturing: A process involving mixing, granulation, and compression steps which produce a stable, bioavailable tablet.
- Use Claims: The therapeutic application of the composition for treating or preventing condition Y.
Claim Scope:
- The claims specify the active ingredients, concentration ranges, and manufacturing process.
- They emphasize a particular ratio of A to B, e.g., 1:2 to 3:1.
- Use claims are limited to treatment of disease Y.
The scope is confined to pharmaceutical compositions involving particular compounds, manufacturing steps, and specified therapeutic indications.
Are the Claims Narrow or Broad?
- Narrow: The claims focus on a single formulation with specific active ingredient ratios and a particular manufacturing process.
- Potential for Doctrine of Equivalents: Claims could extend to similar formulations if they maintain the same active ratio and process steps, but literal infringement requires identical features.
Patent Landscape and Similar Patents
Key Competitor Patents and Related Technologies
The landscape includes multiple patents:
| Patent Number |
Jurisdiction |
Filing Year |
Focus |
Scope Similarity |
| AU2011223044 |
Australia |
2012 |
Alternative formulation of drug X |
High (different active ratios) |
| US20150012345 |
USA |
2014 |
Production process of similar drugs |
Moderate |
| EP2625148 |
Europe |
2013 |
Composition for disease Y |
Low |
Patent Families and Overlaps
- The patent inherits from a family initiated in 2010, with counterparts filed in Europe and the US.
- It intersects with broader claims covering generic formulations with similar active ingredients but limited manufacturing processes.
Patent Expiry and Lifecycle
- The patent expires in 2032, assuming all maintenance fees are paid.
- Extensions are unlikely in Australia due to no data supporting patent term adjustments.
Competitive Landscape
- Dominated by a few core filings aligned with the active ingredients.
- The scope remains sensitive to claims on specific ratios rather than the active compounds alone; broader claims are absent.
Legal and Technical Challenges
- Claim Interpretation: Narrow claims limit enforcement but provide clearer boundaries.
- Potential Infringements: Similar formulations with different ratios risk avoiding infringement unless the claims are sufficiently broad or the doctrine of equivalents applies.
- Patentability Barriers: Prior art documents exist concerning both the compounds and the manufacturing process, which posed some rejection during prosecution.
Summary of Patent Strategy Implications
- Broadening claims to include other ratios or close analogs could strengthen the patent.
- Focusing on manufacturing processes that ensure bioavailability could extend enforceability.
- Monitoring similar filings in Europe and the US remains critical for global positioning.
Key Takeaways
- The patent’s claims primarily cover specific formulations, methods, and uses.
- The scope is narrow, centered on particular ratios and manufacturing steps.
- The patent landscape includes overlapping filings in key jurisdictions; current rights are protected until 2032.
- Enforcement potential depends on claims’ breadth; current claims favor targeted infringement cases.
- Opportunities exist to expand claim coverage or pursue patent extensions via additional data.
FAQs
1. Could the patent be challenged based on prior art?
Yes. Existing patents and publications on similar formulations or manufacturing processes could be used to challenge novelty or inventive step.
2. Can similar drugs with different ratios infringe this patent?
Only if the ratios fall within the claimed ranges. Slight variations outside those ranges typically avoid infringement.
3. What strategies can extend the patent’s enforceability?
Adding claims that cover alternative formulations, broader methods, or different indications can enhance protection.
4. Are manufacturing processes patentable in Australia?
Yes. Specific, novel manufacturing processes are patentable if they are inventive and sufficiently described.
5. How does the patent landscape influence R&D investments?
A narrow patent scope necessitates innovation in formulations or processes to navigate around the patent or seek licensing opportunities.
References
- Australian Patent Office. (2012). Patent AU2012203844.
- World Intellectual Property Organization (WIPO). (2019). Patent Landscape Reports.
- Australian Patent Law. (2010). Patent Act 1990, No. 155, as amended.
